|
West Bend, WI, November 2, 2009 - Spaulding Clinical Research, a newly designed
Phase I Unit provisioned for all types of pharmaceutical trials including the most
complex cardiac safety studies, announces that Ms. Chéri Barta has joined as the Senior
Director, Core ECG Lab Services.
Chéri has over 14 years of experience in Project Management and Business Development
at Covance Cardiac Safety Services and eResearch Technologies. While at Covance she
was a recipient of the Covance Way Award on behalf of the business unit for exceptional
leadership and client satisfaction in 2006, having been nominated six times – a first in the
history of the Company.
Chéri will be responsible for the management, development and implementation of the
strategic plans for the conduct of clinical trials by the ECG Core Lab with an emphasis on
Project Management, Data Management, Logistics and Client Support.
Spaulding Clinical is a Phase I Clinical Research Unit and Electrocardiography Core Lab
located in West Bend, Wisconsin offering a full range of services including thorough
QTc (TQT) studies, first-in-human studies, multiple rising dose, bioavailability and
bioequivalence, drug interaction, food effect studies, PK/PD characterization, and data
collection and management. Spaulding Clinical also offers a full suite of
Electrocardiography Core Lab and over-reading services with state-of-the-art technology
and cardiac expertise. The company’s website is www.spauldingclinical.com
Contact:
Spaulding Clinical
Amanda Baltz
262.306.3324
This e-mail address is being protected from spambots, you need JavaScript enabled to view it
|
News and Events 
